While in all gliomas (LGG and GBM) REST expression was inversely correlated with patients survival as previously reported [23, 24, 52], we found that its high expression is an unfavorable prognostic factor in LGG with the IDH mutation, but a favorable factor in GBM (Fig. 1). The gene discussed is IDH2; the disease is glioblastoma.